Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Bell

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
High-throughput in vitro profiling assays: lessons learnt from experiences at NovartisBernard Faller, Jianling Wang, Alfred Zimmerlin, et al.
Journal of Applied Clinical Medical Physics|February 22, 2025
Quantitative beam optimization for radiotherapy of peripheral lung lesions: A pilot study in stereotactic body radiotherapyHamed Hooshangnejad, Jina Lee, Leslie Bell, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolically Stable tert-Butyl ReplacementDavid Barnes-Seeman, Monish Jain, Leslie Bell, et al.
Journal of Biomolecular Screening|May 14, 2008
Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discoveryLeslie Bell, Shari Bickford, Phong Hung Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
A new structural alert for benzimidazoles: 2,6-dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskYoungshin Kwak, Gary Coppola, Cornelia J Forster, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
High-throughput in vitro profiling assays: lessons learnt from experiences at NovartisBernard Faller, Jianling Wang, Alfred Zimmerlin, et al.
Journal of Applied Clinical Medical Physics|February 22, 2025
Quantitative beam optimization for radiotherapy of peripheral lung lesions: A pilot study in stereotactic body radiotherapyHamed Hooshangnejad, Jina Lee, Leslie Bell, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolically Stable tert-Butyl ReplacementDavid Barnes-Seeman, Monish Jain, Leslie Bell, et al.
Journal of Biomolecular Screening|May 14, 2008
Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discoveryLeslie Bell, Shari Bickford, Phong Hung Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
A new structural alert for benzimidazoles: 2,6-dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskYoungshin Kwak, Gary Coppola, Cornelia J Forster, et al.
Pageof 2